Scleromyxedema

Scleromyxedema, also known as papular mucinosis or Arndt-Gottron disease, is a rare chronic progressive skin disorder characterized by the widespread eruption of firm, waxy, closely spaced papules and plaques associated with skin induration (hardening). The condition results from excessive deposition of mucin (a glycosaminoglycan) in the dermis along with fibroblast proliferation and fibrosis. Scleromyxedema is almost always associated with a monoclonal gammopathy, most commonly an IgG lambda paraprotein, although the exact pathogenic role of this paraprotein remains unclear. The disease is not considered a form of localized lichen myxedematosus, which is a milder condition. The skin manifestations typically include generalized papular eruptions that can coalesce into plaques, leading to thickening and hardening of the skin, particularly on the face, hands, forearms, and trunk. Facial involvement can produce a characteristic leonine facies with deep furrows. Beyond the skin, scleromyxedema can affect multiple organ systems, leading to serious and potentially life-threatening complications. Neurological involvement may include encephalopathy, seizures, coma (known as the dermato-neuro syndrome), and peripheral neuropathy. Cardiovascular, pulmonary, gastrointestinal, renal, and musculoskeletal systems can also be affected. Joint stiffness and decreased mobility due to skin induration are common. Dysphagia may occur from esophageal involvement. There is no universally effective treatment for scleromyxedema, and management remains challenging. Intravenous immunoglobulin (IVIg) is currently considered a first-line therapy and has shown benefit in many patients. Other treatments that have been used with variable success include systemic corticosteroids, thalidomide, lenalidomide, bortezomib, melphalan with or without autologous stem cell transplantation, and plasmapheresis. The disease follows a chronic relapsing course, and long-term monitoring for systemic complications and progression of the paraproteinemia is essential.

Common questions about Scleromyxedema